Media Resources

2017
4 May

Joint Letter to World Health Assembly Delegates | We must delink research and development costs from cancer medicine prices
5 April

2016 Annual Report & Financial Statements
29 March

Report | The Sun Shines on Europe: transparency of financial relationships in the healthcare sector
23 March

ACCISS Study Report | Access to Insulin: Current Challenges and Constraints
20 March

Position Statement: TACD Positive Consumer Agenda – New Rules for the Global Economy
7 March

Media Release: Health Action International start een publiekscampagne tegen stijgende medicijnprijzen
7 March

Media Release: Soaring Medicine Prices the Target Of New Public Campaign Ahead Of 15 March Election
3 March

Media Statement: European Parliament Hits Target in Recommendations for Improving Access to Medicines
2 February

Media Release: European Public Health Advocates Demand Greater Public Returns From European Commission’s Research and Development Programme, Horizon 2020
2 February

Joint Submission to European Commission Public Consultation on Horizon 2020
2016
12 December

Medicines Policy in Moldova
6 December

Fact or Fiction? What Healthcare Professionals Need to Know about Pharmaceutical Marketing
5 December

Prices and Availability of Locally Produced and Imported Medicines in Ethiopia
5 December

Prices and Availability of Locally Produced and Imported Medicines in Tanzania
30 November

Health Systems Advocacy Partnership: Fact Sheet
26 October

Press Release: Health Action International Receives €460,000 Grant from Dutch Ministry of Foreign Affairs to Fight Snakebite Death & Disability in Sub-Saharan Africa
25 October

Press Release: Health Action International Launches Educational Guide to Help EU Healthcare Students & Professionals Counter Ill Effects of Pharmaceutical Marketing
17 October

Joint Letter: Civil Society Urges US Secretary Burwell to Expand Access to Patented Cancer Drugs in Developing Countries
3 October

Press Release: Report Reveals Danger Of TTIP Locking Europe & Us Into Higher Drug Prices, Failed Pharma Innovation Model
1 October

Fact or Fiction: What Healthcare Professionals Need to Know about Pharmaceutical Marketing in the European Union
20 July

56 Non-profit Organisations Question US State Department Pressure Against Global Access to Medicines Initiatives – Letter to US Secretary of State, John Kerry
14 July

Recommendations for EU Governments to Improve Access & Innovation of Needed Medicines
13 July

Measures That Reduced Price of Patented HIV Medicines Should Be Used to Safeguard Access to New Essential Medicines
27 May

WHA69 Intervention on Global Medicine Shortages and the Safety and Accessibility of Children’s Medication
27 May

HAI Co-signs Letter to Obama Administration Regarding Alleged U.S. Interference in Colombian Health Measure
25 May

Snakebite: Call for urgent global action to end death & suffering
2 May

HAI, KEI & STOPAIDS Statement on the WHO Consultative Expert Working Group on R&D
1 May

Measuring Medicine Prices, Availability, Affordability and Price Components (2nd Ed.)
18 April

Civil Society Urges Member States to Support the Dutch EU Presidency’s Vision on Access to Affordable Medicines
15 March

Assessing EU Funding for R&D for Poverty-related and Neglected Diseases